Editorial: visceral fat as a predictor of post‐operative recurrence of Crohn’s disease by Stidham, R. W. & Waljee, A. K.
I N V I T E D E D I T O R I A L S
Editorial: visceral fat as a predictor of post-operative
recurrence of Crohn’s disease
An argument could be made for visceral fat being one of the first
biomarkers of Crohn’s disease (CD). Hypertrophied mesenteric, or
“creeping”, fat encasing affected intestine was reported in the semi-
nal publication describing CD from Oppenheimer and Crohn in
1932.1 Once thought almost incompatible with the diagnosis, the
incidence of obesity in CD has risen dramatically over the last two
decades.2,3 The increasing incidence of CD occurring in parallel with
the obesity epidemic has again raised interest in studying the inter-
action of mesenteric fat and IBD. In place of body mass index (BMI)
measurements, body composition analysis has revealed the associa-
tion of visceral fat with disease activity, complications and post-
operative outcomes in CD.4-6
Holt and colleagues performed a post hoc analysis in 44 of 174
patients from the POCER study to determine whether pre-operative
image-based body composition parameters were associated with
post-operative CD recurrence.7 Disease recurrence at 18 months
following surgery, defined by a Rutgeerts’ score of I2 or greater, was
compared to fat and skeletal muscle area measurements at the L3-
L4 level derived from CT and MR studies using the SliceOmatic body
composition analysis platform (Tomovision, Montreal, QC, Canada).
The authors found that an increased visceral fat area, adjusted for
overall body height and gender (visceral adipose tissue/height index)
was associated with endoscopic disease recurrence (RR: 2.1, 95% CI:
1.5-3.0). Highlighting the value of more granular body composition
data, BMI was not correlated with endoscopic recurrence (P=.614).
These results agree with other work showing standardised visceral
fat measurement (but not BMI) to be correlated with poor CD out-
comes.4-6
Is visceral fat quantification positioned to become a clinically
useful predictor of CD recurrence? At present, more work is needed
to determine the best use, if any, of body composition for improving
post-operative prognostic accuracy. The degree of visceral fat may
be influenced by several factors, including corticosteroid exposure,
prior abdominal surgery, stricturing or penetrating complications and
Crohn’s disease activity itself. The authors recognised this and did
report that high-risk patients (prior surgery, smokers), steroid users
and post-operative treatment intensity did not differ by endoscopic
recurrence status, albeit using univariate analysis. The VHI cut-off
value of >1.5 times the gender mean demonstrated a sensitivity and
specificity of 100% (82%-100%) and 29% (12%-51%), respectively,
for identifying disease recurrence. While visceral fat measures alone
may be insufficient to guide therapeutic escalation, it may still make
a meaningful contribution to models predicting future CD recur-
rence.
Perhaps more valuable than exploring its potential as a biomar-
ker, this study adds to mounting evidence evaluating the associa-
tion between visceral fat and intestinal inflammation. Visceral fat
adipocytes have increased expression of several inflammatory
cytokines including TNF-a, IL-1 and IL-6.8 Adipocyte inflammatory
expression profiles occur not only at hypertrophied fat surround-
ing diseased bowel but also in the distant omental mesentery.
Human observations showing increased translocation of luminal
bacteria to the mesenteric fat of subjects with Crohn’s disease
compared to unaffected patients.9 Questions remain whether vis-
ceral fat proliferation and activity is a contributing cause, or alter-
natively result, of intestinal inflammation. Nonetheless, continued
exploration of the interaction between visceral fat and disease
course is likely to provide important insight into the pathophysiol-
ogy of Crohn’s disease.
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Editorial: visceral fat as a predictor of post-operative
recurrence of Crohn’s disease—Authors’ reply
We are grateful to Drs Stidham and Waljee for their appraisal1 of
our work examining visceral adiposity as a predictor of post-opera-
tive Crohn’s disease recurrence.2 We agree that the study findings
raise two issues: the role of body composition as a biomarker in
Crohn’s disease, and the association of visceral fat with intestinal
inflammation.
As medical treatments for Crohn’s disease multiply, it is impor-
tant that post-operative prophylaxis is appropriately targeted to
ensure optimum results while avoiding unnecessary adverse effects
and cost. A personalised approach may entail risk stratification and
prediction of response to therapy, by considering patient and dis-
ease characteristics. Well-described risk factors include cigarette
smoking, prior intestinal resection, absence of preventative treat-
ment, penetrating disease at index surgery, perianal disease, and his-
tological features of granulomas in the resection specimen and
myenteric plexitis.3 Microbial,4 genetic,5,6 and perhaps body compo-
sition variables may also have a role to play in a composite model.
Stidham and Waljee are right to state that further research is
required to place body composition analysis in place as a clinical
predictor of outcomes in Crohn’s disease, but such analysis may be
more easily accessible in future as automated segmentation tech-
niques7,8 develop. Further areas of related research include differen-
tiation of anatomical fat deposits by functional characteristics, and
identification of metabolically distinct white and brown adipose
tissues.
There are unanswered questions regarding the direction of
causality between alterations in visceral fat and inflammation in
Crohn’s disease. Measurement of intra-abdominal adipose tissue
area is a crude descriptor of the functional activity of the visceral
adipose tissue compartment, and we welcome further research in
this field.
ACKNOWLEDGEMENTS
The authors’ declarations of personal and financial interests are
unchanged from those in the original article.2
D. Q. Holt1,2
G. T. Moore1,2
B. J. G. Strauss1
A. L. Hamilton3,4
P. De Cruz4
M. A. Kamm3,4
1Monash University, Melbourne, Vic., Australia
2Department of Gastroenterology & Hepatology, Monash Health,
Melbourne, Vic., Australia
3Department of Gastroenterology, St Vincent’s Hospital, Melbourne,
Vic., Australia
4University of Melbourne, Melbourne, Vic., Australia
Email: darcy.holt@monashhealth.org
REFERENCES
1. Stidham RW, Waljee AK. Editorial: visceral fat as a predictor of post-
operative recurrence of Crohn’s disease. Aliment Pharmacol Ther.
2017;45:1551-1552.
2. Holt DQ, Moore GT, Strauss BJG, Hamilton AL, De Cruz P, Kamm MA.
Visceral adiposity predicts post-operative Crohn’s disease recurrence.
Aliment Pharmacol Ther. 2017;45:1255-1264.
3. De Cruz P, Kamm MA, Prideaux L, Allen PB, Desmond PV. Postopera-
tive recurrent luminal Crohn’s disease: a systematic review. Inflamm
Bowel Dis. 2012;18:758-777.
4. Wright EK, Kamm MA, Wagner J, et al. Microbial factors associated
with postoperative Crohn’s disease recurrence. J Crohns Colitis.
2017;11:191-203.
1552 | INVITED EDITORIALS
© 2017 John Wiley & Sons Ltd
